Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session 3

2989 - Adverse effects of chemotherapy influence the patients’ quality of life : Analysis of implicated factors

Date

30 Sep 2019

Session

Poster Display session 3

Presenters

Maria Lavdaniti

Citation

Annals of Oncology (2019) 30 (suppl_5): v836-v845. 10.1093/annonc/mdz276

Authors

M. Lavdaniti1, A. Chavela2, A. Chatzinikolaou1, I. Chatzi3, E. Stalika4, D. Palitzika5, E. Drakou6, G. Tzavelas2

Author affiliations

  • 1 Nursing Department, Alexander Technological Educational Institute, 57400 - Thessaloniki/GR
  • 2 Statistics And Insurance Science, University of Piraeus, 18534 - Piraeus/GR
  • 3 2nd Pathology Department, Konstantopouleio General Hospital, 13678 - Athens/GR
  • 4 Lab Of Medical Informatics, Aristotle University of Thessaloniki, 57400 - SIINDOS/GR
  • 5 Nursing, General Hospital "G. Papanikolaou", 57400 - Thessaloniki/GR
  • 6 Surgery Unit, Sismanogleio Hospital, 13678 - Athens/GR
More

Resources

Abstract 2989

Background

Past and recent findings indicate that adverse effects of chemotherapy influence the patients’ quality of life. The aim of this study was to investigate the implicated factors that influenced the perceived symptoms and quality of life in cancer patients during chemotherapy.

Methods

A longitudinal study was conducted in a large hospital in a major city of Northern Greece. A total of 200 cancer patients undergoing chemotherapy in cycle 2 and cycle 3 were participated in the research. Data was collected using Memorial Symptom Assessment Scale (MSAS), Functional Assessment Cancer Therapy (FACT-G) additionally with a questionnaire for the demographic and clinical characteristics. Descriptive and conductive statistical methods were applied.

Results

The vast majority of the participants were middle aged (58.94±9.94 years) men (n = 122, 61%) suffering from lung cancer (n = 98, 48%). Analysis based on the chemotherapy cycle status revealed a significant differences in several factors grouping the patients regarding their chemotherapy cycle status (cycle 2 vs cycle 3). Particularly, feeling nervous level, severity and distress of dizziness and the severity in the way of food tastes [p = 0.014, p = 0.001, p < 0.001, p < 0.001 and p = 0.030, respectively] differed statistically significantly. Moreover, multiple logistic regression analysis revealed that gender (p < 0.001) and physical well-being score (p = 0.005) affected perceived symptoms in MSAS. Furthermore, gender, occupational status, diet, type of cancer and family status influenced the overall quality of life in cycle 2 patients (p = 0.002, p < 0.001, p = 0.002, p < 0.001 and p < 0.001 respectively); however, in cycle 3 patients : gender (p = 0.003), occupational status (p < 0.001), educational status (p < 0.001) and diet (p < 0.001) were referred as the most statistically significant variables that influence the overall quality of life.

Conclusions

In conclusion, we demonstrate that adverse effects of chemotherapy in cancer patients play a critical role for the overall quality of patients’ life. Patients demographic or/ and clinicobiological characteristics seem to influence the appearance of the adverse effects.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.